Search

Botaretigene Sparoparvovec (Johnson & Johnson) for X-Linked Retinitis Pigmentosa

An investigational gene therapy administered by subretinal injection for the treatment of X-linked retinitis pigmentosa due to mutations in the RPGR gene.

Complete this form to request the full report